Integrated Filing- Financial

Aarti Drugs Limited has announced a board meeting on January 29, 2025, to present the financial results for the quarter and nine months ended December 31, 2024. The results indicate a revenue of ₹226.69 crore and a net profit of ₹39.06 crore for the quarter.

The Board has declared an interim dividend of ₹1.00 per equity share, amounting to ₹12.70 crore.

This announcement may positively influence investor sentiment, reflecting strong operational performance despite market challenges.

Moreover, the dividend declaration underscores the company's commitment to returning value to shareholders, potentially enhancing trust and confidence among investors.